Condition
Alcohol Withdrawal Delirium
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 4 (3)
Trial Status
Completed2
Terminated2
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03586089Not ApplicableTerminatedPrimary
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
NCT04156464Phase 4Unknown
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
NCT03877120Phase 4CompletedPrimary
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
NCT01362205Phase 4TerminatedPrimary
Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)
NCT00597701Not ApplicableCompletedPrimary
Treating Alcohol Withdrawal With Oral Baclofen
Showing all 5 trials